Alector (ALEC) Net Margin (2018 - 2026)
Alector's (ALEC) quarterly Net Margin came in at 692.47% in Q2 2026, down 30481.0% year-over-year from N/an in Q2 2025, and up 68.41% quarter-over-quarter from 2192.16% in Q1 2026.
Analysis
Alector (ALEC) Net Margin (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Net Margin for 9 consecutive years, with 692.47% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin fell 30481.0% year-over-year to 692.47% in Q2 2026; TTM through Jun 2026 was 632.66%, a 52151.0% decrease from a year earlier, with the FY2025 full-year figure at 535.9%, down 44248.0% from the prior year.
- Net Margin was 692.47% for Q2 2026 at Alector, up from 2192.16% in the prior quarter.
- Over five years, Net Margin peaked at 42.46% in Q4 2024 and troughed at 2192.16% in Q1 2026.
- A 5-year average of 429.41% and a median of 265.81% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin soared 108706 bps in 2022 and slumped 109061 bps in 2026, its largest moves.
- Over 5 years, Net Margin stood at 152.14% in 2022, then surged by 57 bps to 66.06% in 2023, then surged by 164 bps to 42.46% in 2024, then sank by 369 bps to 114.14% in 2025, then plunged by 507 bps to 692.47% in 2026.
- The last three Net Margin figures came in at 692.47% (Q2 2026), 2192.16% (Q1 2026), and 114.14% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 23.62% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -134.51% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 32.99% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 30.23% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 31.16% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -539.31% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 12.74% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 3.56% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -3.12% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -692.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -692.47% |
| Mar 31, 2026 | -2,192.16% |
| Dec 31, 2025 | -114.14% |
| Sep 30, 2025 | -1,063.40% |
| Jun 30, 2025 | -387.66% |
| Mar 31, 2025 | -1,101.55% |
| Dec 31, 2024 | 42.46% |
| Sep 30, 2024 | -275.19% |
| Jun 30, 2024 | -256.42% |
| Mar 31, 2024 | -227.01% |
| Dec 31, 2023 | -66.06% |
| Sep 30, 2023 | -488.25% |
| Jun 30, 2023 | 2.45% |
| Mar 31, 2023 | -277.10% |
| Dec 31, 2022 | -152.14% |
| Sep 30, 2022 | -310.72% |
| Jun 30, 2022 | 12.38% |
| Mar 31, 2022 | -182.30% |
| Dec 31, 2021 | -342.87% |
| Sep 30, 2021 | 69.40% |